Maricann Announces Appointment of New Chief Financial Officer

Original Post: TORONTO, Ontario (October 3, 2017) 

Maricann Group Inc. (CSE: MARI, OTCQB: MRRCF, FRA: 75M) (“Maricann” or the “Company”) is pleased to announce the appointment of Scott Langille as the Company’s Chief Financial Officer effective October 2, 2017, subject to regulatory approval.

Mr. Langille has over 30 years of experience in the pharmaceutical industry in both Canada and the United States.

To learn more CLick-Here

Origianl Post on maricann.com